Study tests new radiation timing for Kids' brain cancer
NCT ID NCT01351870
Summary
This completed international trial compared two different schedules of radiation therapy for children and young adults (ages 4-21) with standard-risk medulloblastoma, a type of brain tumor. All participants received the same chemotherapy, but were randomly assigned to receive radiation either once a day or twice a day. The main goal was to see if the twice-daily schedule improved survival without the cancer returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDULLOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut Curie
Paris, 75005, France
Conditions
Explore the condition pages connected to this study.